Navigation Links
You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decade's 'Real Nutritional Heroes'
Date:1/5/2009

ability to overcome fatigue, as well as simply feeling better. "Supplemental Corvalen(R) is part of a clinically proven program we've developed that is helping millions of people overcome the debilitating effects of Chronic Fatigue Syndrome and fibromyalgia as well as a general malaise of exhaustion," said Teitelbaum. Corvalen(R) is also used by physicians to treat congestive heart failure and to prepare patients for off-pump bypass surgery(1).

"Bioenergy D-Ribose(TM) also has sweeping applications for healthy people who need more energy every day," said Raj Khankari, Ph.D., CEO of Bioenergy, Inc. "It is already widely used as an effective training and recovery tool by high-performance athletes. We've only scratched the surface on the wide-ranging health and training benefits of this nutritional powerhouse."

Bioenergy, Inc. -- The Ribose Company(TM) -- (http://www.bioenergy.com), recently achieved GRAS (generally recognized as safe) status for D-Ribose from the U.S. Food and Drug Administration. The privately held, Minneapolis-based life sciences company has amassed a large body of scientific literature on the uses of ribose for people across all age and health categories. It has more than 40,000 customers for its proprietary Corvalen(R) products alone, and millions worldwide use Bioenergy D-Ribose(TM) in other functional foods like energy bars (Detour, FastFuel, Marathon) and beverages (SoBe Adrenaline Rush, Vitamin Water, Snapple Antioxidant Water). Currently, Bioenergy D-Ribose(TM) is included as an ingredient in approximately 100 products. The company's core technology lies in the development and commercialization of products based on the physiological benefits of D-Ribose for health and wellness.

    (1) D. Perkowski, MD, S. Wagner, RN, A. Marcus, MD, J. St. Cyr, MD, Ph.D.,
        Saddleback Hospital, Orange Co., CA, "D-Ribose Improves 
'/>"/>
SOURCE Bioenergy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. A Scientist Dechipers the Code to Beautiful, Healthy Skin in The New Science of Perfect Skin
2. With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial Infarction (Heart Attack) and Revascularisation in Stable Coronary Patients
3. PNAS paper and its authors honored for scientific excellence
4. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
5. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
6. Genstar Names Michael Hurt to Its Strategic Advisory Board
7. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
8. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
9. Pharmasset Appoints Michael Rogers as Chief Development Officer
10. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
11. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 US-Australian drug discovery company, ... confirmed it is committed to progressing its ground-breaking technology ... practicable and to ensure the Company delivers the best ... Iain Ross , said the Company currently had ... pre-clinical programs, discovery programs and academic partnerships and initiatives, ...
(Date:7/29/2015)... Station, TX (PRWEB) , ... July 29, 2015 ... ... POD® designer, manufacturer and supplier, announces the launch of their 2nd generation cell ... to the current miniPOD CT, but it also represents a new POD® design. ...
(Date:7/29/2015)... 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) announced ... be released on Thursday, August 13, 2015, before the ... management will host a conference call to discuss the ... release outlining the financial results and business update will ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and reference ...
(Date:7/29/2015)... CA (PRWEB) , ... July 29, 2015 , ... Finding ... the morning is quite normal. Although there are a considerable number of terms in ... understood that this post-sleep material is a mixture of mucus, blood cells, skin cells ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 2What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 3What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 4
... 3 BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) ... a program to develop an IgA protease for,treating ... cleave IgA,complexes, the deposition of which causes IgA ... BioMarin has executed a research,and option agreement with ...
... Vicus Therapeutics, LLC, an,oncology-focused, clinical-stage biopharmaceutical company, ... present at the BMO Capital,Markets Focus on Healthcare ... 2007 at 1:30 p.m. ET at the Millennium ... Therapeutics, Vicus Therapeutics is a privately-held, biopharmaceutical ...
... Dec. 3 Signalife, Inc.,(Amex: SGN ) ... Congress on,Cardiac Pacing and Electrophysiology to be held ... Dr. Muricio Arruda, who has been testing,Signalife,s wireless ... the Cleveland Clinic Heart Center, will,present a prototoype ...
Cached Biology Technology:BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease 2BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease 3BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease 4Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology 2Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology 3
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading ... for its second quarter ended June 30, 2015.  ... million, a decrease of 33% compared to $6.8 million in ... quarter of 2015 was $0.3 million, or $0.01 per diluted ... share, in the same period a year ago.  ...
(Date:7/21/2015)... , July 21, 2015 Passwords ... as seen in the recent U.S. Office of ... solution to the infosec conundrum, but developers and ... stored. To address this dilemma, Biometrics-as-a-Service provider HYPR ... Biometric Tokenization SDK for third party integration. ...
(Date:7/9/2015)... July 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... that it will report financial results for the fourth ... 2015 after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... (iBOL) Secretariat today announced major new funding for the ... Scientific Director, said that four Canadian agencies have made ... investments by these funders to $80 million. , Building ... of Research and Innovation today announced another $8.1 million ...
... immunization against "swine flu" in 1976 might provide individuals ... virus, according to new research from St. Jude investigators. ... 1976 vaccine mounted an enhanced immune response against both ... flu strain that circulated during the 2008-09 flu season. ...
... computational model to uncover gene regulation, the key to how ... The researchers, from The University of Manchester (UK), Aalto ... say the new method identifies targets of regulator genes. ... in our body. An individual cell,s make up (e.g. muscle ...
Cached Biology News:Major funding boost for International Barcode of Life project 2Major funding boost for International Barcode of Life project 3Study links 1976 'swine flu' shot to stronger immune response to 21st century pandemic flu 2Study links 1976 'swine flu' shot to stronger immune response to 21st century pandemic flu 3New computational method to uncover gene regulation 2
...
... Rabbit Polyclonal to Human CELSR3 CELSR3 is ... In mouse, this gene is expressed during ... adult mice and rats in brain, spinal cord, ... isolated from human B-cell/lung/testis, blood, brain, colon, heart/melanocyte/uterus, ...
... plus multi-channel focal drug delivery. Maintain bath ... high-flow bath line while quickly switching 4 ... Pencil.® Steady 37°C at 5 ml/minute flow ... tip. Advanced auto-tuning temperature lock ...
... Immunogen: purified recombinant human ... coli . Physical form: ... filtered solution in phosphate buffered ... (c). WB. Titertest ...
Biology Products: